Hims Semaglutide: How the Program Prescribes and Dispenses

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This Education Hub article covers GLP-1 therapies, weight management protocols, and the genetic variables shaping metabolic decisions. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Hims or its parent company, and no affiliate links or compensation are involved.

Semaglutide is the molecule behind several familiar brand names, and how a telehealth program prescribes and dispenses it is where the practical differences live. This review focuses on the mechanics of a semaglutide prescription through a service like Hims — balanced editorial framing, not a buying recommendation, as of April 2026.

Semaglutide: the molecule behind the brand names

Semaglutide is a GLP-1 receptor agonist, part of a class that also includes liraglutide and dulaglutide, and separate from the GIP/GLP-1 dual agonist tirzepatide. It appears under different FDA-approved brand names and can also be prepared as a compounded product. The molecule is the constant; the brand and the sourcing pathway are the variables worth reading closely.

How the program prescribes semaglutide

Hims (Hims & Hers Health) operates as subscription telehealth. A licensed provider conducts a virtual evaluation and, if criteria are met, writes a semaglutide prescription. Whether it is filled as an FDA-approved branded product or as a compounded preparation depends on the program and is shown at intake. Confirm the current arrangement on Hims's official website.

Branded semaglutide versus compounded semaglutide

A semaglutide prescription can route to a retail pharmacy for an FDA-approved brand product or to a 503A compounding pharmacy for a compounded version. The two are regulated differently and can differ in cost and presentation. This distinction — not the brand name in the advertising — is the detail that most shapes what a patient actually receives.

The dispensing and follow-up workflow

The path is consistent across telehealth GLP-1 programs: an intake covering weight, medical history, and medications; a licensed clinician's review; prescription fulfillment through retail or 503A pharmacy; and follow-up supporting titration and side-effect management. Provider type, pharmacy partner, and subscription tier vary by brand. This review provides no dosing figures or injection technique.

STEP and the semaglutide evidence

Semaglutide's weight-management evidence comes largely from the STEP program (The New England Journal of Medicine, 2021); tirzepatide comparators include SURMOUNT (NEJM 2022) and SURMOUNT-OSA (NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary. Evidence for the class does not translate into a predicted result for any one person.

The genetic baseline semaglutide works within

A semaglutide plan does not read the biology it acts on. GLP1R, the receptor gene semaglutide targets directly, sits with TCF7L2 (tied to glucose homeostasis and GLP-1 secretion), FTO (fat-mass and obesity-associated), and MC4R (a melanocortin receptor central to satiety). These pathway-level variants do not predict response to semaglutide; they describe the metabolic terrain a clinician prescribes into.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including TCF7L2, FTO, and MC4R variants that shape baseline GLP-1 and appetite biology. That upstream read is the test before you invest approach: informed conversation over guesswork.

Not affiliated: PlexusDx has no affiliation with Hims and no commercial relationship with any company reviewed here.

Related reading on PlexusDx: Where To Buy Ozempic, Where To Get Ozempic, Alternatives For Ozempic, Discount Ozempic.

Compare the PlexusDx approach: the Weight Management Protocols pair semaglutide and tirzepatide with genetic context, or take the Precision Peptide Genetic Test to map your GLP-1 pathway first.

Frequently Asked Questions

How does a telehealth program prescribe semaglutide?

A licensed provider conducts a virtual evaluation and, if eligibility criteria are met, writes a prescription. It is then filled through either a retail pharmacy for an FDA-approved branded product or a 503A compounding pharmacy for compounded semaglutide. A prescription is not automatic, and follow-up supports titration over time.

Is compounded semaglutide the same as the branded product?

No. Compounded semaglutide is prepared by a state-licensed 503A pharmacy under a prescription, while the branded product is an FDA-approved medication dispensed at retail. The two are regulated differently and can differ in cost and presentation. Confirm which pathway a program uses on its own website before enrolling.

How does the Precision Peptide Genetic Test relate to semaglutide?

It does not predict how you will respond to semaglutide or any compound. It reads pathway-level variants in TCF7L2 and FTO, and MC4R that describe your baseline GLP-1 and appetite biology — upstream context that applies no matter which program prescribes or how the semaglutide is sourced.

Where should I confirm sourcing and pricing?

Only on the brand's own website, where branded-versus-compounded sourcing and pricing are published and change over time. Telehealth GLP-1 totals run roughly $200 to $700+ per month as of April 2026 depending on compound, tier, and pathway. Treat third-party figures as unverified until you check the source.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Disclaimer: This article is educational. PlexusDx is not affiliated with Hims and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.